Mucosal Vaccines

Most infectious agents enter the body at mucosal surfaces and therefore mucosal immune responses function as a first line of defence. Protective mucosal immune responses are most effectively induced by mucosal immunization through oral, nasal, rectal or vaginal routes, but the vast majority of vaccines in use today are administered by injection. Immunisation involves the delivery of antigens to the mucosal immune system (dispersed or organised into units such as Peyer’s patches in the intestine or the nasal-associated lymphoid tissue in the oropharangeal cavity). The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.

    Related Conference of Mucosal Vaccines

    June 09-09, 2021

    Global Summit on Vaccines and Immunology

    Chicago, USA
    June 09-10, 2021

    Global Summit on HIV-AIDS and STDs

    Chicago, USA
    June 09-10, 2021

    Global Summit on Vaccines & Emerging Diseases

    Chicago, USA
    June 14-15, 2021

    Global Summit on Hepatitis Vaccine

    Rome, Italy
    July 29-30, 2021

    33rd Annual Congress on Immunology and Vaccinations

    Vancouver, Canada
    December 01-02, 2021

    41st Global Summit and Expo on Vaccines & Immunology

    Frankfurt, Germany

    Mucosal Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in